Connection

WILLIAM G WIERDA to Signaling Lymphocytic Activation Molecule Family Member 1

This is a "connection" page, showing publications WILLIAM G WIERDA has written about Signaling Lymphocytic Activation Molecule Family Member 1.
  1. A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemia. PLoS One. 2011; 6(12):e28277.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.